Ischemic colitis, irritable bowel syndrome, and tegaserod - An alternative viewpoint

被引:7
作者
Shetzline, MA [1 ]
Cohard-Radice, M [1 ]
Joelsson, B [1 ]
机构
[1] Nova Pharmaceut Corp, E Hanover, NJ 07936 USA
来源
PHARMACOTHERAPY | 2005年 / 25卷 / 11期
关键词
D O I
10.1592/phco.2005.25.11.1684
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1684 / 1685
页数:2
相关论文
共 6 条
[1]   Misdiagnosis of ischemic colitis as irritable bowel syndrome. [J].
Brinker, A ;
Senior, J ;
Beitz, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) :P33-P33
[2]   Occurrence of colon ischemia in relation to irritable bowel syndrome [J].
Cole, JA ;
Cook, SF ;
Sands, BE ;
Ajene, AN ;
Miller, DP ;
Walker, AM .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (03) :486-491
[3]   Tegaserod-associated ischemic colitis [J].
DiBaise, JK .
PHARMACOTHERAPY, 2005, 25 (04) :620-625
[4]   5-HT3 receptor antagonists, alosetron and cilansetron, impair mesenteric blood flow in rats [J].
Holzer, P ;
Painsipp, E ;
Weber, E ;
Pfannkuche, HJ .
GASTROENTEROLOGY, 2003, 124 (04) :A148-A149
[5]  
*NOV PHARM CORP, 2005, DAT FIL
[6]  
Sharma A, 2004, GUT, V53, pA66